Given the significance of VASP phosphorylation in PCa migration, therapeutic strategies targeting molecules like NO, LPA, and MC-LR to inhibit or antagonize VASP phosphorylation, or directly block VASP phosphorylation, offer promising avenues for therapeutic interventions. Here, VASP is linked to posterior cortical atrophy.